Angelo, Laura S <br/><br/>
Combining curcumin (diferuloylmethane) and heat shock protein inhibition for neurofibromatosis 2 treatment: analysis of response and resistance pathways.  [electronic resource] 

 -  Molecular cancer therapeutics  Nov 2011 
 - 2094-103 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-11-0243  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Apoptosis--drug effects<br/>Benzhydryl Compounds--pharmacology<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Curcumin--pharmacology<br/>Drug Resistance, Neoplasm--genetics<br/>Drug Synergism<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>HSP72 Heat-Shock Proteins--genetics<br/>Heat-Shock Proteins--antagonists & inhibitors<br/>Humans<br/>Myosin-Light-Chain Phosphatase--metabolism<br/>Neurofibromatosis 2--drug therapy<br/>Neurofibromin 2--metabolism<br/>Phosphorylation<br/>Protein Binding<br/>Pyrrolidinones--pharmacology<br/>Signal Transduction--drug effects<br/>Up-Regulation--drug effects